During the previous grant period the laboratory used the first cDNA encoding a cocaine-sensitive biogenic amine transporter, the human norepinephrine transporter (NET), as the basis for the isolation and characterization of a cDNA encoding the dopamine transporter (DAT) which has been proposed to be the most significant site of action for the euphoric and addictive effects of cocaine. Although many neurobiological issues need to be investigated before the biology of psychomotor stimulant addiction can be explained, the studies proposed in this continuing renewal application will continue to build on the view that significant insights will come from the fundamental biology of the transporters themselves. This proposal outlines plans for the further exploration of basic structure-function relationships, electrogenic properties and cell biological regulation of DAT and NET, areas that provided some of the most interesting observations during the previous grant period. Continuing studies using chimeras, selected point mutants and cysteine-scanning and modification (SCAM) approaches are being coupled with kinetic analyses of transport, electrophysiological approaches and binding studies to further probe the structure of substrate and antagonist binding sites, as well as the permeation pathway for ions. Recent work from this laboratory has shown that dopamine uptake by DAT is an electrogenic and voltage-dependent process. Furthermore, members of Na+/CI- -dependent family of neurotransmitter transporters, including DAT, can mediate macroscopic ionic currents which are not stoichiometrically linked to substrate movement. The mechanism and consequences of these currents, in particular their potential to activate voltage-gated calcium channels and intracellular signaling pathways, will be examined. The proposed experiments also aim to examine how intracellular signaling mechanisms regulate the number of carriers expressed at the cell surface, focusing on a particularly striking effect of PKC activation on the internalization and sequestration of NET and DAT proteins. Our overall goal is to relate protein structural features to novel functional properties and regulatory mechanisms, and to establish the contributions of the DA and NE carriers to neuronal function.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DA007595-07
Application #
2693774
Study Section
Special Emphasis Panel (SRCD (04))
Program Officer
Colvis, Christine
Project Start
1992-01-10
Project End
2001-11-30
Budget Start
1997-12-10
Budget End
1998-11-30
Support Year
7
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Hong, Weimin Conrad; Yano, Hideaki; Hiranita, Takato et al. (2017) The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats. J Biol Chem 292:11250-11261
Wheeler, David S; Underhill, Suzanne M; Stolz, Donna B et al. (2015) Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine. Proc Natl Acad Sci U S A 112:E7138-47
Underhill, Suzanne M; Wheeler, David S; Amara, Susan G (2015) Differential regulation of two isoforms of the glial glutamate transporter EAAT2 by DLG1 and CaMKII. J Neurosci 35:5260-70
Hong, Weimin C; Amara, Susan G (2013) Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons. FASEB J 27:2995-3007
Larsen, Mads Breum; Sonders, Mark S; Mortensen, Ole Valente et al. (2011) Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation. J Neurosci 31:6605-15
Hong, Weimin C; Amara, Susan G (2010) Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J Biol Chem 285:32616-26
Fontana, Andréia C K; Sonders, Mark S; Pereira-Junior, Olavo S et al. (2009) Two allelic isoforms of the serotonin transporter from Schistosoma mansoni display electrogenic transport and high selectivity for serotonin. Eur J Pharmacol 616:48-57
Mortensen, Ole Valente; Larsen, Mads Breum; Prasad, Balakrishna M et al. (2008) Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking. Mol Biol Cell 19:2818-29
Mortensen, Ole V; Amara, Susan G (2006) Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters. J Neurochem 98:1531-40
Mortensen, Ole V; Amara, Susan G (2003) Dynamic regulation of the dopamine transporter. Eur J Pharmacol 479:159-70

Showing the most recent 10 out of 32 publications